Avita MedicalRCEL

那斯達克 · USD
10.45
+0.24
(+2.35%)
收盤 09/17 03:59 (UTC+8)
09/17 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.11
  • 0.15
  • 0.20
  • 0.18
  • 0.19
  • 0.18
  • 0.17
  • 0.18
  • 0.19
  • 0.22
icon
  • -21.78
  • 36.84
  • 28.63
  • -5.83
  • 0.59
  • -0.52
  • -7.36
  • 3.24
  • 9.29
  • 12.73
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
21,702
19,251
17,615
17,063
18,418
18,514
18,406
19,546
15,195
11,104
營業成本
3,9353,5233,3043,1873,4702,8332,2803,1902,1111,513
營業毛利
17,767
15,728
14,311
13,876
14,948
15,681
16,126
16,356
13,084
9,591
營業費用
24,62224,53124,71923,02726,09627,50826,08330,163-26,797
研發費用
5,0785,6295,6913,7485,1166,2844,8505,4294,8875,194
推銷及管理費用
19,54418,90219,02819,27920,98021,22421,23324,73423,82021,603
非經常性項目費用
----------
其他營業費用
----------
營業利益
-6,855
-8,803
-10,408
-9,151
-11,148
-11,827
-9,957
-13,807
-15,623
-17,206
其他收入及費用
688-39520-2,7512,484-791-315-1,0661,610-66
利息費用
1,4631,4241,2501,2691,2521,2331,2981,3601,3471,356
稅前純益
-7,630
-10,622
-11,638
-13,171
-9,916
-13,851
-11,570
-16,233
-15,360
-18,628
所得稅
33-11-17164819-283330
稅後純益
-7,663
-10,611
-11,621
-13,187
-9,920
-13,859
-11,589
-16,205
-15,393
-18,658
基本每股稅後盈餘(元)
-0.25-0.35-0.38-0.46-0.38-0.53-0.44-0.62-0.60-0.73
稀釋每股稅後盈餘(元)
-0.25-0.35-0.37-0.47-0.37-0.53-0.44-0.63-0.59-0.73
基本平均股數(千股)
30749.0030540.0030384.0028393.0026367.0026253.0026146.0025983.0025760.0025637.00
稀釋平均股數(千股)
30749.0030540.0030384.0028393.0026367.0026253.0026146.0025983.0025760.0025637.00
還原基本每股稅後盈餘(元)
-0.25-0.35-0.38-0.46-0.38-0.53-0.44-0.62-0.60-0.73
還原稀釋每股稅後盈餘(元)
-0.25-0.35-0.37-0.47-0.37-0.53-0.44-0.63-0.59-0.73
還原基本平均股數(千股)
30,74930,54030,38428,39326,36726,25326,14625,98325,76025,637
還原稀釋平均股數(千股)
30,74930,54030,38428,39326,36726,25326,14625,98325,76025,637
EBITDA(千元)
-5,605-8,648-9,772-11,359-8,177-12,225-10,058-14,890-14,284-17,746

大家都在看

HOT